ClinicalTrials.Veeva

Menu

POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

H

Helse Stavanger HF

Status

Enrolling

Conditions

Chronic Pain
Opioid Use

Treatments

Behavioral: POINT1

Study type

Interventional

Funder types

Other

Identifiers

NCT05828121
POINTstavanger

Details and patient eligibility

About

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.

Full description

The investigators know that patients suffering from chronic pain need good treatment. The use of opioids for chronic, non-cancer related pain may seem appropriate in the short term, but can often have negative consequences for both the individual and society in the long term.

Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway.

Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease.

In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life.

Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway.

To achieve the main goal, the investigators will focus on pain patients and their doctors, as increasing opioid use may occur through the patient-doctor interaction.

Methods

The project will develop and test a non-drug interventions that consist of an interdisciplinary group treatment .

Financing The Research Council of Norway

Cooperation St. Olavs Hospital

Stavanger Hospital Trust

City of Stavanger

National Institute of Public Health (FHI)

Alcohol and Drug Research Western Norway (KoRFor)

Foreningen for kroniske smertepasienter (FKS) Norwegian Forum of Disabled Peoples' Organizations (SAFO)

Cooperation with other projects Injury Prevention and Outcomes following Trauma

Enrollment

90 estimated patients

Sex

All

Ages

18 to 67 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • non-malignant, chronic pain
  • Registered in Stavanger municipality
  • Consent to participation.
  • Age 18 - 67 years
  • Pain duration <10 years

Exclusion criteria

  • malignant pain condition

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

90 participants in 1 patient group

Point1
Experimental group
Description:
Receiving treatment
Treatment:
Behavioral: POINT1

Trial contacts and locations

1

Loading...

Central trial contact

Kine Gjesdal, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems